NanoViricides Inc Stock OTC Bulletin Board
Equities
US6300871042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 20.56M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.38
x | P/E ratio 2025 * |
-1.57
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.69% |
Managers | Title | Age | Since |
---|---|---|---|
Anil Diwan
CEO | Chief Executive Officer | 66 | 05-03-31 |
Meeta Vyas
DFI | Director of Finance/CFO | 66 | 13-05-12 |
Jayant Tatake
CTO | Chief Tech/Sci/R&D Officer | - | 10-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Zucker
BRD | Director/Board Member | 62 | 20-11-12 |
Anil Diwan
CEO | Chief Executive Officer | 66 | 05-03-31 |
Director/Board Member | 73 | 20-02-06 |
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |